Hiroaki Todo

Dr. Hiroaki Todo

Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado, Japan
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2017 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Hiroaki TodoHiroaki Todo
Hiroaki Todo
Excised human skin is utilized for in vitro permeation experiments to evaluate the safety and effect of topically-applied drugs by measuring its skin permeation and concentration. However, ethical considerations are the major problem for using human skin to evaluate percutaneous absorption. Moreover, large variations have been found among human skin specimens as a result of differences in age, race, and anatomical donor site. Animal skins are used to predict the in vivo human penetration/permeation of topically-applied chemicals. In the present review, skin characteristics, such as thickness of skin, lipid content, hair follicle density, and enzyme activity in each model are compared to human skin. In addition, intra- and inter-individual variation in animal models, permeation parameter correlation between animal models and human skin, and utilization of cultured human skin models are also descried. Pig, guinea pig, and hairless rat are generally selected for this purpose. Each animal model has advantages and weaknesses for utilization in in vitro skin permeation experiments. Understanding of skin permeation characteristics such as permeability coefficient (P), diffusivity (D), and partition coefficient (K) for each skin model would be necessary to obtain better correlations for animal models to human skin permeation.

1 January 2015 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
TUTakashi Uchida
Takashi Uchida
WKWesam R. Kadhum
Wesam R. Kadhum
SKSayumi Kanai
Sayumi Kanai
Hiroaki TodoHiroaki Todo
Hiroaki Todo
TOTakeshi Oshizaka
Takeshi Oshizaka
Kenji SugibayashiKenji Sugibayashi
Kenji Sugibayashi

1 July 2019 in Cosmetics
Verified
Journal Article
Open access
PDF file
Kenji SugibayashiKenji Sugibayashi
Kenji Sugibayashi
EYEddy Yusuf
Eddy Yusuf
Hiroaki TodoHiroaki Todo
Hiroaki Todo
SDSabrina Dahlizar
Sabrina Dahlizar
PSPajaree Sakdiset
Pajaree Sakdiset
GSGerard Lee See
Gerard Lee See
The demand for halal cosmetic products among the 2.4 billion Muslim consumers worldwide is increasing. However, the demand for halal cosmetics remains unmet because cosmetics production is dominated by non-halal cosmetic manufacturers, whose production methods may not conform with the requirements of halal science. The development of halal cosmetics and the assessment of their product performance is still in its infancy. The integration of halal science in the manufacture of most cosmetic products remains inadequate. Moreover, there is a global dearth of guiding documents on the development and assessment techniques in the production of comprehensively halal cosmetics. This paper aims to abridge existing literature and knowledge of halal and cosmetic science in order to provide essential technical guidance in the manufacture of halal cosmetics. In addition, the adoption of these methods addresses the unique ethical issues associated with conformance of cosmetics’ product performance to religious practices and halal science. It highlights the applicability of established methods in skin science in the assessment of halal cosmetics.

1 April 2007 in Journal of Controlled Release
Verified
Journal Article
Closed access
XWXue-Ming Wu
Xue-Ming Wu
Hiroaki TodoHiroaki Todo
Hiroaki Todo
Kenji SugibayashiKenji Sugibayashi
Kenji Sugibayashi

1 February 2003 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
HOHirokazu Okamoto
Hirokazu Okamoto
SNSeiko Nishida
Seiko Nishida
Hiroaki TodoHiroaki Todo
Hiroaki Todo
YSYuki Sakakura
Yuki Sakakura
KIKotaro Iida
Kotaro Iida
KDKazumi Danjo
Kazumi Danjo

24 November 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DSDaisuke Sasaki
Daisuke Sasaki
KKKosuke Kusamori
Kosuke Kusamori
YTYukiya Takayama
Yukiya Takayama
SIShoko Itakura
Shoko Itakura
Hiroaki TodoHiroaki Todo
Hiroaki Todo
MNMakiya Nishikawa
Makiya Nishikawa
Recent studies showed that plant-derived nanoparticles (NPs) can be easily produced in high yields and have potential applications as therapeutic agents or delivery carriers for bioactive molecules. In this study, we selected corn as it is inexpensive to grow and mass-produced globally. Super sweet corn was homogenized in water to obtain corn juice, which was then centrifuged, filtered through a 0.45-μm-pore size syringe filter, and ultracentrifuged to obtain NPs derived from corn, or corn-derived NPs (cNPs). cNPs obtained were approximately 80 nm in diameter and negatively charged (− 17 mV). cNPs were taken up by various types of cells, including colon26 tumor cells and RAW264.7 macrophage-like cells, with selective reduction of the proliferation of colon26 cells. Moreover, cNPs induced tumor necrosis factor-α release from RAW264.7 cells. cNPs and RAW264.7 in combination significantly suppressed the proliferation of colon26/fluc cells. Daily intratumoral injections of cNPs significantly suppressed the growth of subcutaneous colon26 tumors in mice, with no significant body weight loss. These results indicate excellent anti-tumor activity of cNPs.